Blau Farmacêutica Future Growth
Future criteria checks 3/6
Blau Farmacêutica is forecast to grow earnings and revenue by 18.2% and 11.7% per annum respectively. EPS is expected to grow by 17.2% per annum. Return on equity is forecast to be 13.5% in 3 years.
Key information
18.2%
Earnings growth rate
17.2%
EPS growth rate
| Biotechs earnings growth | 31.7% |
| Revenue growth rate | 11.7% |
| Future return on equity | 13.5% |
| Analyst coverage | Good |
| Last updated | 13 Nov 2024 |
Recent future growth updates
Recent updates
Results: Blau Farmacêutica S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates
Nov 07
Blau Farmacêutica S.A.'s (BVMF:BLAU3) 25% Share Price Surge Not Quite Adding Up
Nov 06Blau Farmacêutica S.A.'s (BVMF:BLAU3) 31% Price Boost Is Out Of Tune With Earnings
Aug 29Is Blau Farmacêutica (BVMF:BLAU3) A Risky Investment?
Jun 28Lacklustre Performance Is Driving Blau Farmacêutica S.A.'s (BVMF:BLAU3) 26% Price Drop
Feb 01What Does The Future Hold For Blau Farmacêutica S.A. (BVMF:BLAU3)? These Analysts Have Been Cutting Their Estimates
May 14Blau Farmacêutica S.A. Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next
Feb 24Getting In Cheap On Blau Farmacêutica S.A. (BVMF:BLAU3) Is Unlikely
Oct 14Robust Earnings May Not Tell The Whole Story For Blau Farmacêutica (BVMF:BLAU3)
Aug 17Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,173 | 325 | 48 | 361 | 8 |
| 12/31/2025 | 1,937 | 283 | 33 | 355 | 8 |
| 12/31/2024 | 1,780 | 237 | 89 | 423 | 2 |
| 9/30/2024 | 1,686 | 187 | 88 | 333 | N/A |
| 6/30/2024 | 1,575 | 216 | 2 | 238 | N/A |
| 3/31/2024 | 1,474 | 240 | 20 | 284 | N/A |
| 12/31/2023 | 1,373 | 250 | -44 | 221 | N/A |
| 9/30/2023 | 1,352 | 317 | -7 | 253 | N/A |
| 6/30/2023 | 1,351 | 312 | 8 | 262 | N/A |
| 3/31/2023 | 1,352 | 354 | 33 | 229 | N/A |
| 12/31/2022 | 1,407 | 363 | -8 | 172 | N/A |
| 9/30/2022 | 1,390 | 314 | 104 | 267 | N/A |
| 6/30/2022 | 1,348 | 313 | 96 | 252 | N/A |
| 3/31/2022 | 1,354 | 301 | -21 | 137 | N/A |
| 12/31/2021 | 1,366 | 325 | -24 | 154 | N/A |
| 9/30/2021 | 1,354 | 354 | 9 | 166 | N/A |
| 6/30/2021 | 1,338 | 335 | -13 | 146 | N/A |
| 3/31/2021 | 1,289 | 309 | 13 | 208 | N/A |
| 12/31/2020 | 1,182 | 254 | 53 | 224 | N/A |
| 9/30/2020 | 1,066 | 238 | -17 | 183 | N/A |
| 6/30/2020 | 1,029 | 214 | 76 | 245 | N/A |
| 3/31/2020 | 1,008 | 203 | 103 | 217 | N/A |
| 12/31/2019 | 978 | 200 | 125 | 221 | N/A |
| 9/30/2019 | 987 | 186 | 72 | 131 | N/A |
| 6/30/2019 | 938 | 177 | 24 | 82 | N/A |
| 3/31/2019 | 819 | 129 | 19 | 77 | N/A |
| 12/31/2018 | 782 | 123 | 32 | 83 | N/A |
| 9/30/2018 | 677 | 90 | 27 | 67 | N/A |
| 6/30/2018 | 616 | 78 | N/A | 90 | N/A |
| 3/31/2018 | 634 | 110 | N/A | 137 | N/A |
| 12/31/2017 | 618 | 103 | N/A | 127 | N/A |
| 12/31/2016 | 431 | 32 | N/A | 46 | N/A |
| 12/31/2015 | 379 | 22 | N/A | 42 | N/A |
| 12/31/2014 | 299 | 17 | N/A | 14 | N/A |
| 12/31/2013 | 271 | 15 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: BLAU3's forecast earnings growth (18.2% per year) is above the savings rate (10.4%).
Earnings vs Market: BLAU3's earnings (18.2% per year) are forecast to grow faster than the BR market (12.6% per year).
High Growth Earnings: BLAU3's earnings are forecast to grow, but not significantly.
Revenue vs Market: BLAU3's revenue (11.7% per year) is forecast to grow faster than the BR market (7.4% per year).
High Growth Revenue: BLAU3's revenue (11.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: BLAU3's Return on Equity is forecast to be low in 3 years time (13.5%).